Peter Hnik, M.D., MHSc

Chief Medical Officer

Dr. Hnik received his medical degree from the Medical Faculty of Charles University of Prague in 1981. After practicing at the Eye Clinic of the Charles University Hospital where he was involved, among others, in treatment of glaucoma, ocular inflammation, diseases of retina and neuro-ophthalmology, he later joined the Eye Clinic of the University of British Columbia as part of the glaucoma research group. He received his Master of Health Sciences degree from the University of British Columbia in 1999. Prior to joining iVeena Delivery Systems, Dr. Hnik has been serving as Chief Medical Officer with iCo Therapeutics Inc. leading all clinical programs, participating in meetings with financial institutions/investors and assessing new in-licensing opportunities. Before iCo Therapeutics, Dr. Hnik served as Associate Director of Clinical Research with QLT Inc., designing and directing clinical trials in AMD and diabetic retinopathy. He has authored numerous ocular publications and presentations at international forums. Dr. Hnik is a member of the Association for Research in Vision and Ophthalmology (ARVO), the American Academy of Ophthalmology (AAO), the European Society of Retina Specialists (EURETINA), the Drug Information Association (DIA), and the New York Academy of Sciences (NYAS).